Abstract
A series of novel, multisubstrate, bicyclic pyrimidine nucleoside inhibitors of human thymidine phosphorylase (TP) is described. Thymidine phosphorylase has been implicated in angiogenesis and plays a significant role in tumor progression and metastasis. The presence and orientation of the phosphonate moiety (acting as a phosphate mimic) in these derivatives were critical for inhibitory activity. The most active compounds possessed a phosphonate group in an endo orientation. This was consistent with molecular modeling results that showed the endo isomer protein-ligand complex to be lower in energy than the exo complex.
MeSH terms
-
Bridged Bicyclo Compounds, Heterocyclic / chemical synthesis*
-
Bridged Bicyclo Compounds, Heterocyclic / chemistry
-
Bridged Bicyclo Compounds, Heterocyclic / pharmacology
-
Enzyme Inhibitors / chemical synthesis*
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Humans
-
Models, Molecular
-
Molecular Structure
-
Pyrimidine Nucleosides / chemical synthesis*
-
Pyrimidine Nucleosides / chemistry
-
Pyrimidine Nucleosides / pharmacology
-
Structure-Activity Relationship
-
Thymidine Phosphorylase / antagonists & inhibitors*
Substances
-
Bridged Bicyclo Compounds, Heterocyclic
-
Enzyme Inhibitors
-
Pyrimidine Nucleosides
-
Thymidine Phosphorylase